Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Human Surgical Implantation of Single Piece ADAPT® Treated 3D ALR (Aortic Leaflet Repair), Feasibility and Clinical Safety Study

NCT04178213 is registered in ClinicalTrials.gov with Anteris Technologies Ltd. as lead sponsor.

NCT NCT04178213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04178213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Human Surgical Implantation of Single Piece ADAPT® Treated 3D ALR (Aortic Leaflet Repair), Feasibility and Clinical Safety Study
Lead sponsor
Anteris Technologies Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
March 26, 2020
Completion date
June 30, 2022
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic insufficiency, aortic stenosis